ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2026
Adherence to evidence-based guidelines for the management of candiduria in a tertiary care center in Riyadh: A retrospective cross-sectional study.
Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
According to the Infectious Disease Society of America (IDSA) 2016 guidelines for the management of candidiasis, the presence of Candida in the urine in asymptomatic patients is usually a colonization rather than an infection, which does not require antifungals treatment. This study aims to assess the management of candiduria at a tertiary hospital in Riyadh, Saudi Arabia, in comparison to IDSA guidelines and its impact on patient outcomes. This was a single-center, retrospective, cross-sectional study conducted at a tertiary care center in Riyadh, Saudi Arabia. All adult hospitalized patients (≥ 18 years old) who had a positive urine culture for a Candida species from Jan 2023 to Dec 2023 were included in the study. All Patients' data were extracted from electronic health records. IRB approval (E-23-8172) was granted. A total of 217 urine cultures that were positive for a Candida species were included in our study. 166 (76.5%) candiduria episodes were managed in accordance with the IDSA recommendations, while 51 (23.5%) were treated against these recommendations. Urinary symptoms were present significantly more in those who were treated against IDSA recommendations (4.2% vs 74.5%, P < 0.00001). The in-hospital mortality rate (36.7% vs 29.4%, P = 0.34) did not differ significantly between the two groups. This study showed that around 77% of candiduria patients were managed according to the IDSA guidelines. However, while the degree of adherence to the guidelines was high in asymptomatic patients, most of the symptomatic patients were managed inappropriately. Adherence to the guidelines' recommendations did not significantly affect patients' outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.